Staphylococcus Aureus Infection
Favorable European opinion received for Altastaph
Published in Medical Letter on the CDC and FDA, October 23rd, 2005
OMP designation acknowledges the significant medical need for a product and can provide development and commercialization advantages. Based upon this favorable opinion, Nabi Biopharmaceuticals expects to receive the formal OMP designation from the European Commission later this year.
OMP designation is reserved for medicines being developed for rare diseases. Orphan medicinal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Breast Cancer Prognosis
Obesity increases mortality risk in women with breast cancer - HIV/AIDS Diagnosis
Rapid HIV antibody assays for detecting recent seroconversion modified - Rotavirus Vaccine Development
Candidate rotavirus vaccines derived from neonatal strains developed - Smallpox Vaccine
Outcome of smallpox vaccination in healthcare workers described - West Nile Virus
Immunoassay to detect anti-West Nile virus IgM antibodies developed - Allergy Medicine
Bifidobacterium bifidum G9-1 suppresses IgE production - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
